| 140 | Humans (MeSH) |
| 89 | SARS-CoV-2 (MeSH) |
| 78 | Pandemics (MeSH) |
| 78 | COVID-19 (MeSH) |
| 61 | Animals (MeSH) |
| 60 | Coronavirus Infections (virology) |
| 52 | Male (MeSH) |
| 47 | Female (MeSH) |
| 41 | Coronavirus Infections (epidemiology) |
| 37 | Pneumonia, Viral (virology) |
| 36 | Betacoronavirus (genetics) |
| 35 | Middle Aged (MeSH) |
| 31 | Pneumonia, Viral (epidemiology) |
| 30 | Adult (MeSH) |
| 28 | Coronavirus Infections (veterinary) |
| 27 | Phylogeny (MeSH) |
| 26 | Spike Glycoprotein, Coronavirus (genetics) |
| 26 | Mutation (MeSH) |
| 24 | COVID-19 (virology) |
| 23 | Genome, Viral (MeSH) |
| 23 | Betacoronavirus (MeSH) |
| 20 | SARS-CoV-2 (genetics) |
| 20 | Genetic Variation (MeSH) |
| 19 | Aged (MeSH) |
| 16 | COVID-19 (epidemiology) |
| 15 | Coronavirus Infections (prevention & control) |
| 14 | Spike Glycoprotein, Coronavirus (metabolism) |
| 14 | Spike Glycoprotein, Coronavirus (chemistry) |
| 14 | Pneumonia, Viral (complications) |
| 14 | China (epidemiology) |
| 13 | RNA, Viral (genetics) |
| 13 | Genotype (MeSH) |
| 13 | Coronavirus Infections (complications) |
| 12 | Poultry Diseases (virology) |
| 12 | Genome, Viral (genetics) |
| 12 | Coronavirus Infections (drug therapy) |
| 11 | Evolution, Molecular (MeSH) |
| 11 | Coronavirus Infections (immunology) |
| 11 | Coronavirus Infections (diagnosis) |
| 11 | Chlorocebus aethiops (MeSH) |
| 11 | COVID-19 (diagnosis) |
| 11 | Betacoronavirus (isolation & purification) |
| 10 | Young Adult (MeSH) |
| 10 | Vero Cells (MeSH) |
| 10 | Spike Glycoprotein, Coronavirus (immunology) |
| 10 | Protein Binding (MeSH) |
| 10 | Pneumonia, Viral (prevention & control) |
| 10 | Pneumonia, Viral (genetics) |
| 10 | Pandemics (prevention & control) |
| 10 | Mice (MeSH) |
| 10 | Coronavirus Infections (pathology) |
| 10 | Coronavirus Infections (genetics) |
| 10 | COVID-19 (genetics) |
| 10 | COVID-19 (complications) |
| 10 | Betacoronavirus (physiology) |
| 10 | Betacoronavirus (immunology) |
| 10 | Angiotensin-Converting Enzyme 2 (metabolism) |
| 10 | Adolescent (MeSH) |
| 9 | Swine (MeSH) |
| 9 | SARS-CoV-2 (pathogenicity) |
| 9 | Polymorphism, Single Nucleotide (MeSH) |
| 9 | Pneumonia, Viral (drug therapy) |
| 9 | Models, Molecular (MeSH) |
| 9 | Infectious bronchitis virus (genetics) |
| 9 | Coronavirus Infections (transmission) |
| 9 | Chickens (MeSH) |
| 9 | Binding Sites (MeSH) |
| 9 | Betacoronavirus (pathogenicity) |
| 9 | Angiotensin-Converting Enzyme 2 (genetics) |
| 9 | Angiotensin-Converting Enzyme 2 (MeSH) |
| 8 | Pneumonia, Viral (diagnosis) |
| 8 | High-Throughput Nucleotide Sequencing (MeSH) |
| 8 | COVID-19 (transmission) |
| 8 | Antibodies, Viral (immunology) |
| 8 | Antibodies, Neutralizing (immunology) |
| 7 | Virus Internalization (MeSH) |
| 7 | Viral Vaccines (immunology) |
| 7 | Swine Diseases (virology) |
| 7 | Serine Endopeptidases (genetics) |
| 7 | SARS-CoV-2 (isolation & purification) |
| 7 | SARS-CoV-2 (immunology) |
| 7 | Protein Domains (MeSH) |
| 7 | Protein Conformation (MeSH) |
| 7 | Porcine epidemic diarrhea virus (genetics) |
| 7 | Pneumonia, Viral (transmission) |
| 7 | Pneumonia, Viral (immunology) |
| 7 | Peptidyl-Dipeptidase A (genetics) |
| 7 | Cohort Studies (MeSH) |
| 7 | COVID-19 (immunology) |
| 7 | Betacoronavirus (metabolism) |
| 7 | Amino Acid Substitution (MeSH) |
| 6 | Treatment Outcome (MeSH) |
| 6 | Severity of Illness Index (MeSH) |
| 6 | Recombination, Genetic (MeSH) |
| 6 | Receptors, Virus (genetics) |
| 6 | Pneumonia, Viral (physiopathology) |
| 6 | Peptidyl-Dipeptidase A (metabolism) |
| 6 | HEK293 Cells (MeSH) |
| 6 | Coronavirus Infections (physiopathology) |
| 6 | Cell Line (MeSH) |
| 6 | COVID-19 (prevention & control) |
| 6 | Betacoronavirus (classification) |
| 6 | Antiviral Agents (therapeutic use) |
| 6 | Amino Acid Sequence (MeSH) |
| 6 | Aged, 80 and over (MeSH) |
| 5 | Whole Genome Sequencing (MeSH) |
| 5 | Virus Replication (MeSH) |
| 5 | Viral Vaccines (administration & dosage) |
| 5 | Viral Proteins (genetics) |
| 5 | Viral Envelope Proteins (genetics) |
| 5 | Serine Endopeptidases (metabolism) |
| 5 | Sequence Analysis, RNA (MeSH) |
| 5 | SARS-CoV-2 (drug effects) |
| 5 | Receptors, Virus (metabolism) |
| 5 | Prevalence (MeSH) |
| 5 | Porcine epidemic diarrhea virus (isolation & purification) |
| 5 | Pneumonia, Viral (therapy) |
| 5 | Pneumonia, Viral (pathology) |
| 5 | Pneumonia, Viral (MeSH) |
| 5 | Infectious bronchitis virus (classification) |
| 5 | Host-Pathogen Interactions (genetics) |
| 5 | Guillain-Barre Syndrome (diagnosis) |
| 5 | Genetic Predisposition to Disease (MeSH) |
| 5 | Feces (virology) |
| 5 | Disease Models, Animal (MeSH) |
| 5 | Coronavirus Infections (therapy) |
| 5 | COVID-19 (metabolism) |
| 5 | COVID-19 (drug therapy) |
| 5 | Betacoronavirus (drug effects) |
| 5 | Base Sequence (MeSH) |
| 5 | Antiviral Agents (pharmacology) |
| 5 | Antibodies, Viral (blood) |
| 5 | Angiotensin-Converting Enzyme 2 (chemistry) |
| 4 | Virus Replication (drug effects) |
| 4 | Viral Nonstructural Proteins (genetics) |
| 4 | Time Factors (MeSH) |
| 4 | Swine Diseases (epidemiology) |
| 4 | Surveys and Questionnaires (MeSH) |
| 4 | Specific Pathogen-Free Organisms (MeSH) |
| 4 | Sequence Deletion (MeSH) |
| 4 | SARS-CoV-2 (metabolism) |
| 4 | Risk Factors (MeSH) |
| 4 | Poultry Diseases (epidemiology) |
| 4 | Molecular Epidemiology (MeSH) |
| 4 | Molecular Docking Simulation (MeSH) |
| 4 | Italy (epidemiology) |
| 4 | Infectious bronchitis virus (isolation & purification) |
| 4 | Gene Frequency (MeSH) |
| 4 | Gene Expression (MeSH) |
| 4 | Disease Management (MeSH) |
| 4 | Diarrhea (virology) |
| 4 | Diarrhea (veterinary) |
| 4 | Databases, Genetic (MeSH) |
| 4 | Coronavirus Infections (MeSH) |
| 4 | Coronavirus Envelope Proteins (MeSH) |
| 4 | Chiroptera (virology) |
| 4 | China (MeSH) |
| 4 | Child, Preschool (MeSH) |
| 4 | Child (MeSH) |
| 4 | COVID-19 Vaccines (immunology) |
| 4 | COVID-19 (therapy) |
| 4 | Betacoronavirus (chemistry) |
| 4 | Antibodies, Neutralizing (blood) |
| 4 | Alleles (MeSH) |
| 3 | Virus Internalization (drug effects) |
| 3 | Viral Tropism (MeSH) |
| 3 | Viral Nonstructural Proteins (chemistry) |
| 3 | Species Specificity (MeSH) |
| 3 | Sequence Analysis, DNA (MeSH) |
| 3 | Sequence Alignment (MeSH) |
| 3 | Selection, Genetic (MeSH) |
| 3 | SARS-CoV-2 (physiology) |
| 3 | SARS-CoV-2 (classification) |
| 3 | Reverse Transcriptase Polymerase Chain Reaction (MeSH) |
| 3 | Retrospective Studies (MeSH) |
| 3 | Real-Time Polymerase Chain Reaction (MeSH) |
| 3 | Public Policy (MeSH) |
| 3 | Protein Stability (MeSH) |
| 3 | Protein Multimerization (MeSH) |
| 3 | Protein Interaction Domains and Motifs (MeSH) |
| 3 | Prognosis (MeSH) |
| 3 | Pregnancy (MeSH) |
| 3 | Porcine epidemic diarrhea virus (physiology) |
| 3 | Porcine epidemic diarrhea virus (immunology) |
| 3 | Porcine epidemic diarrhea virus (classification) |
| 3 | Pneumonia, Viral (metabolism) |
| 3 | Peptidyl-Dipeptidase A (chemistry) |
| 3 | Open Reading Frames (MeSH) |
| 3 | Molecular Dynamics Simulation (MeSH) |
| 3 | Miller Fisher Syndrome (etiology) |
| 3 | Middle East Respiratory Syndrome Coronavirus (immunology) |
| 3 | Mice, Inbred BALB C (MeSH) |
| 3 | Mesocricetus (MeSH) |
| 3 | Lung (virology) |
| 3 | Lung (pathology) |
| 3 | Lung (metabolism) |
| 3 | Lung (diagnostic imaging) |
| 3 | Linkage Disequilibrium (MeSH) |
| 3 | Kinetics (MeSH) |
| 3 | Infectious bronchitis virus (physiology) |
| 3 | Immunogenicity, Vaccine (MeSH) |
| 3 | Hospitalization (MeSH) |
| 3 | High-Throughput Nucleotide Sequencing (methods) |
| 3 | Guillain-Barre Syndrome (virology) |
| 3 | Guillain-Barre Syndrome (etiology) |
| 3 | Genomics (methods) |
| 3 | Genomics (MeSH) |
| 3 | Genome-Wide Association Study (MeSH) |
| 3 | Europe (epidemiology) |
| 3 | Epidemiological Monitoring (MeSH) |
| 3 | England (epidemiology) |
| 3 | Disease Progression (MeSH) |
| 3 | Diarrhea (epidemiology) |
| 3 | Diagnosis, Differential (MeSH) |
| 3 | Cryoelectron Microscopy (MeSH) |
| 3 | Cricetinae (MeSH) |
| 3 | Coronavirus Infections (mortality) |
| 3 | Coronavirus Infections (metabolism) |
| 3 | Coronavirus 3C Proteases (MeSH) |
| 3 | Coronavirus (genetics) |
| 3 | Computational Biology (methods) |
| 3 | Chickens (virology) |
| 3 | Cells, Cultured (MeSH) |
| 3 | COVID-19 (psychology) |
| 3 | Basic Reproduction Number (statistics & numerical data) |
| 3 | Antibodies, Neutralizing (pharmacology) |
| 3 | Antibodies, Neutralizing (chemistry) |
| 3 | Alveolar Epithelial Cells (virology) |
| 2 | Whole Exome Sequencing (MeSH) |
| 2 | Waste Water (virology) |
| 2 | Virus Replication (physiology) |
| 2 | Virus Replication (genetics) |
| 2 | Virulence (genetics) |
| 2 | Virulence (MeSH) |
| 2 | Viral Proteins (immunology) |
| 2 | Viral Nonstructural Proteins (antagonists & inhibitors) |
| 2 | Viral Load (drug effects) |
| 2 | Viral Envelope Proteins (chemistry) |
| 2 | Vaccines, Attenuated (immunology) |
| 2 | Vaccination (veterinary) |
| 2 | United States (epidemiology) |
| 2 | United Kingdom (epidemiology) |
| 2 | Travel-Related Illness (MeSH) |
| 2 | Trachea (virology) |
| 2 | Toll-Like Receptors (genetics) |
| 2 | Toll-Like Receptor 7 (genetics) |
| 2 | Toll-Like Receptor 3 (genetics) |
| 2 | Th1 Cells (immunology) |
| 2 | Swine Diseases (transmission) |
| 2 | Swine Diseases (pathology) |
| 2 | Spike Glycoprotein, Coronavirus (administration & dosage) |
| 2 | Social Isolation (psychology) |
| 2 | Single-Domain Antibodies (immunology) |
| 2 | Single-Cell Analysis (MeSH) |
| 2 | Serial Passage (MeSH) |
| 2 | Sequence Analysis, RNA (veterinary) |
| 2 | Sequence Analysis, Protein (MeSH) |
| 2 | SARS-CoV-2 (growth & development) |
| 2 | SARS-CoV-2 (chemistry) |
| 2 | Respiration, Artificial (MeSH) |
| 2 | Recombinant Proteins (genetics) |
| 2 | Receptors, Virus (chemistry) |
| 2 | Receptors, Coronavirus (MeSH) |
| 2 | RNA-Dependent RNA Polymerase (genetics) |
| 2 | RNA-Dependent RNA Polymerase (antagonists & inhibitors) |
| 2 | RNA-Binding Proteins (genetics) |
| 2 | RNA, Viral (metabolism) |
| 2 | RNA, Viral (MeSH) |
| 2 | RNA, Messenger (genetics) |
| 2 | Quarantine (psychology) |
| 2 | Quarantine (MeSH) |
| 2 | Protein Engineering (MeSH) |
| 2 | Prospective Studies (MeSH) |
| 2 | Poultry Diseases (prevention & control) |
| 2 | Porcine epidemic diarrhea virus (pathogenicity) |
| 2 | Polymorphism, Genetic (MeSH) |
| 2 | Point Mutation (MeSH) |
| 2 | Pneumonia, Viral (psychology) |
| 2 | Pneumonia, Viral (mortality) |
| 2 | Phylogeography (MeSH) |
| 2 | North America (epidemiology) |
| 2 | Nervous System Diseases (etiology) |
| 2 | Nervous System Diseases (diagnosis) |
| 2 | Nasopharynx (virology) |
| 2 | Mutagenesis (MeSH) |
| 2 | Molecular Typing (MeSH) |
| 2 | Molecular Sequence Annotation (MeSH) |
| 2 | Molecular Diagnostic Techniques (MeSH) |
| 2 | Middle East Respiratory Syndrome Coronavirus (drug effects) |
| 2 | Mice, Transgenic (MeSH) |
| 2 | Mice, Inbred C57BL (MeSH) |
| 2 | Membrane Proteins (genetics) |
| 2 | Longitudinal Studies (MeSH) |
| 2 | Kidney Transplantation (MeSH) |
| 2 | Kidney (pathology) |
| 2 | Intestines (virology) |
| 2 | Internet (MeSH) |
| 2 | Internationality (MeSH) |
| 2 | Infectious bronchitis virus (pathogenicity) |
| 2 | Infant, Newborn (MeSH) |
| 2 | India (epidemiology) |
| 2 | Immunosuppressive Agents (therapeutic use) |
| 2 | Immunoglobulin G (blood) |
| 2 | Immunization, Secondary (MeSH) |
| 2 | Immunization (methods) |
| 2 | Immunization (MeSH) |
| 2 | Immunity, Innate (drug effects) |
| 2 | Hypoxia (etiology) |
| 2 | Hydroxychloroquine (therapeutic use) |
| 2 | Host-Pathogen Interactions (drug effects) |
| 2 | Host Specificity (MeSH) |
| 2 | Health Behavior (MeSH) |
| 2 | Haplotypes (MeSH) |
| 2 | HIV-1 (immunology) |
| 2 | Guillain-Barre Syndrome (therapy) |
| 2 | Guillain-Barre Syndrome (physiopathology) |
| 2 | Glycine (genetics) |
| 2 | Global Health (MeSH) |
| 2 | Genetic Fitness (MeSH) |
| 2 | Gene Expression Profiling (MeSH) |
| 2 | Furin (metabolism) |
| 2 | Furin (genetics) |
| 2 | Follow-Up Studies (MeSH) |
| 2 | Fever (etiology) |
| 2 | Eutheria (virology) |
| 2 | Disease Outbreaks (veterinary) |
| 2 | Disease Outbreaks (prevention & control) |
| 2 | Disease Outbreaks (MeSH) |
| 2 | Dipeptidyl Peptidase 4 (metabolism) |
| 2 | Dipeptidyl Peptidase 4 (genetics) |
| 2 | Cytokine Release Syndrome (diagnosis) |
| 2 | Cysteine Endopeptidases (chemistry) |
| 2 | Cross-Sectional Studies (MeSH) |
| 2 | Cross Reactions (MeSH) |
| 2 | Coronavirus, Bovine (genetics) |
| 2 | Coronavirus Infections (psychology) |
| 2 | Coronavirus (classification) |
| 2 | Convalescence (MeSH) |
| 2 | Computer Simulation (MeSH) |
| 2 | Comorbidity (MeSH) |
| 2 | Communicable Disease Control (MeSH) |
| 2 | Clinical Laboratory Techniques (MeSH) |
| 2 | Cell Line, Tumor (MeSH) |
| 2 | Cattle (MeSH) |
| 2 | Case-Control Studies (MeSH) |
| 2 | COVID-19 Vaccines (therapeutic use) |
| 2 | COVID-19 Vaccines (genetics) |
| 2 | COVID-19 Vaccines (MeSH) |
| 2 | COVID-19 Testing (MeSH) |
| 2 | COVID-19 Nucleic Acid Testing (methods) |
| 2 | COVID-19 (physiopathology) |
| 2 | COVID-19 (pathology) |
| 2 | COVID-19 (mortality) |
| 2 | COVID-19 (blood) |
| 2 | Betacoronavirus (ultrastructure) |
| 2 | Apolipoprotein L1 (genetics) |
| 2 | Antiviral Agents (metabolism) |
| 2 | Antiviral Agents (chemistry) |
| 2 | Antiviral Agents (chemical synthesis) |
| 2 | Antibodies, Neutralizing (genetics) |
| 2 | Antibodies, Monoclonal (immunology) |
| 2 | Alveolar Epithelial Cells (metabolism) |
| 2 | Age Factors (MeSH) |
| 2 | Adjuvants, Immunologic (administration & dosage) |
| 1 | rab GTP-Binding Proteins (genetics) |
| 1 | Zoonoses (transmission) |
| 1 | Workload (statistics & numerical data) |
| 1 | Whole Genome Sequencing (methods) |
| 1 | Weight Loss (drug effects) |
| 1 | Water-Electrolyte Balance (MeSH) |
| 1 | Wastewater-Based Epidemiological Monitoring (MeSH) |
| 1 | Vomiting (MeSH) |
| 1 | Viverridae (virology) |
| 1 | Vitamins (blood) |
| 1 | Vitamins (adverse effects) |
| 1 | Vitamins (administration & dosage) |
| 1 | Vision Disorders (metabolism) |
| 1 | Vision Disorders (etiology) |
| 1 | Vision Disorders (diagnosis) |
| 1 | Viruses (genetics) |
| 1 | Virus Cultivation (methods) |
| 1 | Virus Cultivation (MeSH) |
| 1 | Viroporin Proteins (MeSH) |
| 1 | Virion (ultrastructure) |
| 1 | Virion (metabolism) |
| 1 | Viremia (blood) |
| 1 | Viral Vaccines (therapeutic use) |
| 1 | Viral Vaccines (chemistry) |
| 1 | Viral Tropism (physiology) |
| 1 | Viral Regulatory and Accessory Proteins (metabolism) |
| 1 | Viral Regulatory and Accessory Proteins (genetics) |
| 1 | Viral Proteins (physiology) |
| 1 | Viral Nonstructural Proteins (metabolism) |
| 1 | Viral Nonstructural Proteins (immunology) |
| 1 | Viral Matrix Proteins (genetics) |
| 1 | Viral Matrix Proteins (chemistry) |
| 1 | Viral Matrix Proteins (antagonists & inhibitors) |
| 1 | Viral Load (MeSH) |
| 1 | Viral Fusion Proteins (genetics) |
| 1 | Viral Envelope Proteins (immunology) |
| 1 | Viral Envelope Proteins (administration & dosage) |
| 1 | Vietnam (MeSH) |
| 1 | Vesicular stomatitis Indiana virus (metabolism) |
| 1 | Vesicular stomatitis Indiana virus (genetics) |
| 1 | Vertebrates (genetics) |
| 1 | Vertebrates (classification) |
| 1 | Vaping (pathology) |
| 1 | Vaping (adverse effects) |
| 1 | Vaccines, Subunit (administration & dosage) |
| 1 | Vaccines, Inactivated (immunology) |
| 1 | Vaccines, DNA (immunology) |
| 1 | Vaccines, DNA (administration & dosage) |
| 1 | Vaccines, Attenuated (administration & dosage) |
| 1 | Vaccines, Attenuated (MeSH) |
| 1 | Vaccination (methods) |
| 1 | Vaccination (MeSH) |
| 1 | Upper Extremity (MeSH) |
| 1 | Up-Regulation (genetics) |
| 1 | United States (ethnology) |
| 1 | United States (MeSH) |
| 1 | United Kingdom (MeSH) |
| 1 | Ultrasonography (veterinary) |
| 1 | Ultrasonography (statistics & numerical data) |
| 1 | Ultrasonography (MeSH) |
| 1 | Ubiquitin-Protein Ligases (immunology) |
| 1 | Ubiquitin-Protein Ligases (genetics) |
| 1 | Turkeys (MeSH) |
| 1 | Trinidad and Tobago (MeSH) |
| 1 | Travel (MeSH) |
| 1 | Translational Medical Research (MeSH) |
| 1 | Transfection (MeSH) |
| 1 | Transduction, Genetic (MeSH) |
| 1 | Transcription, Genetic (physiology) |
| 1 | Transcription, Genetic (immunology) |
| 1 | Transcription, Genetic (genetics) |
| 1 | Tomography, X-Ray Computed (MeSH) |
| 1 | Toll-Like Receptors (metabolism) |
| 1 | Toll-Like Receptors (immunology) |
| 1 | Toll-Like Receptors (chemistry) |
| 1 | Toll-Like Receptor 8 (metabolism) |
| 1 | Toll-Like Receptor 8 (genetics) |
| 1 | Toll-Like Receptor 8 (chemistry) |
| 1 | Toll-Like Receptor 7 (metabolism) |
| 1 | Toll-Like Receptor 7 (chemistry) |
| 1 | Toll-Like Receptor 3 (metabolism) |
| 1 | Toll-Like Receptor 3 (chemistry) |
| 1 | Tissue Donors (MeSH) |
| 1 | Time-to-Treatment (statistics & numerical data) |
| 1 | Thrombotic Microangiopathies (MeSH) |
| 1 | Thrombocytopenia (virology) |
| 1 | Thrombocytopenia (immunology) |
| 1 | Thrombocytopenia (genetics) |
| 1 | Thermodynamics (MeSH) |
| 1 | Thalamus (MeSH) |
| 1 | Thailand (MeSH) |
| 1 | Texas (epidemiology) |
| 1 | Temperature (MeSH) |
| 1 | Telemedicine (MeSH) |
| 1 | Taste Disorders (virology) |
| 1 | Taste Disorders (genetics) |
| 1 | Tandem Mass Spectrometry (MeSH) |
| 1 | Takotsubo Cardiomyopathy (therapy) |
| 1 | Takotsubo Cardiomyopathy (etiology) |
| 1 | Takotsubo Cardiomyopathy (diagnostic imaging) |
| 1 | Taiwan (epidemiology) |
| 1 | Tachycardia (physiopathology) |
| 1 | THP-1 Cells (MeSH) |
| 1 | T-Lymphocytes, Cytotoxic (physiology) |
| 1 | T-Lymphocytes (physiology) |
| 1 | T-Lymphocytes (immunology) |
| 1 | Systemic Inflammatory Response Syndrome (virology) |
| 1 | Systemic Inflammatory Response Syndrome (immunology) |
| 1 | Switzerland (MeSH) |
| 1 | Swine Diseases (prevention & control) |
| 1 | Swine Diseases (genetics) |
| 1 | Swine Diseases (drug therapy) |
| 1 | Swine (virology) |
| 1 | Sweden (epidemiology) |
| 1 | Surge Capacity (MeSH) |
| 1 | Suppressor of Cytokine Signaling 1 Protein (genetics) |
| 1 | Structure-Activity Relationship (MeSH) |
| 1 | Structural Homology, Protein (MeSH) |
| 1 | State Medicine (MeSH) |
| 1 | Spleen (immunology) |
| 1 | Spike Glycoprotein, Coronavirus (ultrastructure) |
| 1 | Spike Glycoprotein, Coronavirus (physiology) |
| 1 | Spike Glycoprotein, Coronavirus (isolation & purification) |
| 1 | Spike Glycoprotein, Coronavirus (drug effects) |
| 1 | Spike Glycoprotein, Coronavirus (MeSH) |
| 1 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization (MeSH) |
| 1 | Spatio-Temporal Analysis (MeSH) |
| 1 | Spain (epidemiology) |
| 1 | Spain (MeSH) |
| 1 | Social Isolation (MeSH) |
| 1 | Snakes (virology) |
| 1 | Small Molecule Libraries (pharmacology) |
| 1 | Single-Domain Antibodies (pharmacology) |
| 1 | Single-Domain Antibodies (chemistry) |
| 1 | Singapore (epidemiology) |
| 1 | Signal Transduction (genetics) |
